← FDA DRUG APPROVALS
FDA ANDA · ANDA207096
SODIUM PHENYLACETATE AND SODIUM BENZOATE
Sponsor: AILEX PHARMS LLC
APPLICATION
ANDA207096
TYPE
ANDA
ORIGINAL APPROVAL
2016-02-24
LATEST ACTION
2016-02-24
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
SODIUM PHENYLACETATE AND SODIUM BENZOATEPrescription
SODIUM BENZOATE 10%, SODIUM PHENYLACETATE 10% (5GM/50ML · SOLUTION · INTRAVENOUS
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.